Summit Therapeutics Inc. Common Stock (SMMT) Stock Price

SMMTStock

$13.36−51.41%52W

Market Cap$10.66B

P/E—

PEG Ratio—

Div yield—

Beta-1.62

SMMT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-31.08%

Price vs S&P 500 (4W)-1.62%

VGM Score18.49

Book Value / Share (Quarterly)$0.79

P/TBV (Annual)6.75x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.58

Price vs S&P 500 (YTD)-39.17%

Net Profit Margin (TTM)-9027.08%

EPS (TTM)$-1.12

10-Day Avg Trading Volume6.29M

EPS Excl Extra (TTM)$-1.12

EPS (Annual)$-0.31

ROI (Annual)-56.93%

Net Profit Margin (5Y Avg)-5207.57%

Cash / Share (Quarterly)$0.87

ROA (Last FY)-50.81%

EBITD / Share (TTM)$-1.14

ROE (5Y Avg)-216.65%

Operating Margin (TTM)-8108.33%

Cash Flow / Share (Annual)$-0.42

P/B Ratio17.99x

P/B Ratio (Quarterly)17.95x

Net Income / Employee (Annual)$-835,200

EV / Revenue (TTM)11371.52x

Net Interest Coverage (TTM)-121.35x

ROA (TTM)-141.92%

EPS Incl Extra (Annual)$-0.31

Current Ratio (Annual)9.87x

Quick Ratio (Quarterly)6.67x

3-Month Avg Trading Volume5.24M

52-Week Price Return-51.41%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.60

P/S Ratio (Annual)15966.23x

Asset Turnover (Annual)0.00x

52-Week High$30.05

Operating Margin (5Y Avg)-4960.39%

EPS Excl Extra (Annual)$-0.31

CapEx CAGR (5Y)9.36%

26-Week Price Return-19.84%

Quick Ratio (Annual)9.78x

13-Week Price Return-27.13%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)6.96x

Enterprise Value$10.92B

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-2.46%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-11095.77%

Cash / Share (Annual)$0.92

3-Month Return Std Dev62.54%

Net Income / Employee (TTM)$-3,230,500

ROE (Last FY)-56.93%

Net Interest Coverage (Annual)-67.22x

EPS Basic Excl Extra (Annual)$-0.31

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.12

Receivables Turnover (Annual)0.00x

ROI (TTM)-168.93%

P/S Ratio (TTM)11808.36x

Pretax Margin (5Y Avg)-5211.66%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.60

Price vs S&P 500 (52W)-69.72%

Year-to-Date Return-27.22%

5-Day Price Return-0.70%

EPS Normalized (Annual)$-0.31

ROA (5Y Avg)-99.04%

Net Profit Margin (Annual)-11095.77%

Month-to-Date Return-2.23%

Cash Flow / Share (TTM)$-1.21

EBITD / Share (Annual)$-0.31

Operating Margin (Annual)-10153.52%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-117.59%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.12

P/TBV (Quarterly)6.75x

P/B Ratio (Annual)19.76x

Pretax Margin (TTM)-9027.08%

Book Value / Share (Annual)$0.85

Price vs S&P 500 (13W)-29.93%

Beta-1.62x

Revenue / Share (TTM)$0.00

ROE (TTM)-168.93%

52-Week Low$12.07

vGradeF

mGradeD

vgmGradeF

SMMT Earnings Surprise History

Q2 25-0.57est. -0.07

Q3 25-0.23est. -0.04

Q4 25-0.21est. -0.01

Q1 26-0.18est. -0.21

Q2 26-0.21est. -0.21

SMMT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.92

3.75

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$67.01

About Summit Therapeutics Inc. Common Stock

Summit Therapeutics is a biopharmaceutical company focused on developing novel antibiotics for serious infectious diseases. Its lead product candidate, ridinilazole, is an orally administered antibiotic designed to treat Clostridioides difficile infections (CDI). The company operates in the United States and United Kingdom.